Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in Southern India

被引：35
作者：
Kuraparthy S. [1 ]
Reddy K.M. [2 ]
Yadagiri L.A. [4 ]
Yutla M. [3 ]
Venkata P.B. [2 ]
Kadainti S.V.S. [6 ]
Reddy R.P.V. [5 ]
机构：
[1] Department of Medical Oncology, Sri Venkateswara Institute of Medical Sciences, Tirupati
[2] Department of Pathology, Sri Venkateswara Institute of Medical Sciences, Tirupati
[3] Department of General Surgery, Sri Venkateswara Institute of Medical Sciences, Tirupati
[4] Department of Radiology, Sri Venkateswara Institute of Medical Sciences, Tirupati
[5] Department of General Surgery, S.V.R.R. General Hospital, Tirupati
[6] Department of Statistics, S.V. University, Tirupati
来源：
World Journal of Surgical Oncology | / 5卷 / 1期
关键词：
Breast Cancer; Lymph Edema; Operable Breast Cancer; Modify Radical Mastectomy; Population Base Cancer Registry;
D O I：
10.1186/1477-7819-5-56
中图分类号：
学科分类号：
摘要：
Background: Breast cancer incidence in India is on rise. We report epidemiological, clinical and survival patterns of breast cancer patients from community perspective. Methods: All breast cancer patients treated at this hospital from July 2000 to July 2005 were included. All had cytological or histological confirmation of breast cancer. TNM guidelines for staging and Immunohistochemistry to assess the receptor status were used. Either lumpectomy with axillary lymph node dissection or Modified radical mastectomy (MRM) was done for operable breast cancer, followed by 6 cycles of adjuvant chemotherapy with FAC or CMF regimens to patients with pT >1 cm or lymph node positive or estrogen receptor negative and radiotherapy to patients after breast conservation surgery, pT size > 5 cm, 4 or more positive nodes and stage IIIB disease. Patients with positive Estrogen receptor or Progesterone receptor were advised Tamoxifene 20 mg per day for 3 years. Descriptive analysis was performed. Independent T test and Chi-square test were used. Overall survival time was computed by Kaplan - Meier method. Results: Of 1488 cancer patients, 122 (8.2%) had breast cancer. Of 122 patients, 96.7% had invasive breast carcinoma and 3.3% had sarcoma. 94% came from the rural and semi urban areas. Premenopausal women were 27%. The median age was 50 years. Stage I-6.8%, II-45.8%, III-22%, IV-6.8%, Bilateral breast cancer - 2.5%. The mean pT size was 3.9 cm. ER and PR were positive in 31.6% and 28.1% respectively. MRM was done in 93.8%, while 6.3% patients underwent breast conservation surgery. The mean of the lymph nodes dissected were 3. CMF and FAC regimens were used in 48.8% and 51.2% of patients respectively. FAC group were younger than the CMF group (43.6 yr vs. 54 yrs, P = 0.000). Toxicities were more in FAC than CMF group, alopecia (100% vs. 26.2%), grade2 or more emesis (31.8% vs. 9.2%), grade2 or more fatigue (40.9% vs.19%), anemia (43.1% vs. 16.6%). Median Survival for the cohort was 50.8 months. ER positive patients had better median survival (P = 0.05). Conclusion: MRM was the most frequent surgical option. CMF and FAC showed equivalent survival. FAC chemotherapy was more toxic than CMF. ER positive tumors have superior survival. Overall 3 year survival was 70 percent. © 2007 Kuraparthy et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 19 条
[1]  
Veronesi U., Cascinelli N., Mariani L., Greco M., Saccozzi R., Luini A., Aguilar M., Marubini E., Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer, N Engl J Med, 347, pp. 1227-1232, (2002)
[2]  
Development of Cancer Atlas of India - A Project of National Cancer Registry Program (Indian Council of Medical Research), First All India Report, 1, pp. 11-18, (2002)
[3]  
Yeole B.B., Kurkure A.P., An epidemiological assessment of increasing incidence and trends in breast cancer in Mumbai and other sites in India, during the last two decades, Asian Pac J Cancer Prev, 4, pp. 51-56, (2003)
[4]  
Sambasivaiah K., Kumaraswamy reddy M., Venkataramanappa M., Phanindra B., Lakshmi A.Y., Sarma K.V.S., Cancer Patterns in the Rayalaseema Region of Andhra Pradesh, Indian J Med Paediatric Oncol, 25, pp. 9-15, (2004)
[5]  
Morris A.D., Morris R.D., Wilson J.F., White J., Steinberg S., Okunieff P., Arriagada R., Le M.G., Blichert-Toft M., van Dongen J.A., Breast-conserving therapy vs. mastectomy in early-stage breast cancer: A meta-analysis of 10-year survival, Cancer J Sci Am, 3, pp. 6-12, (1997)
[6]  
Fisher B., Anderson S., Bryant J., Margolese R.G., Deutsch M., Fisher E.R., Jeong J.H., Wolmark N., Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer, N Engl J Med, 347, pp. 1233-1241, (2002)
[7]  
Wilson R.E., Donegan W.L., Mettlin C., Natarajan N., Smart C.R., Murphy G.P., The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons, Surg Gynecol Obstet, 159, pp. 309-318, (1984)
[8]  
Farrow D.C., Hunt W.C., Samet J.M., Geographic variation in the treatment of localized breast cancer, N Engl J Med, 326, pp. 1097-1101, (1992)
[9]  
Raina V., Bhutani M., Bedi R., Sharma A., Deo S.V., Shukla N.K., Mohanti B.K., Rath G.K., Clinical features and prognostic factors of early breast cancer at a major cancer center in North India, Indian J Cancer, 42, pp. 40-45, (2005)
[10]  
Akhtar S.S., Nadrah H.M., Assessment of the quality of breast cancer care: A single institutional study from Saudi Arabia, Int J Qual Health Care, 17, pp. 301-305, (2005)
12